Lucid Diagnostics Inc.
LUCD
$1.26
$0.086.78%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -55.26M | -61.83M | -45.53M | -44.82M | -46.66M |
Total Depreciation and Amortization | 880.00K | 887.00K | 1.17M | 1.57M | 1.98M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 12.57M | 19.40M | 4.65M | 4.58M | 6.76M |
Change in Net Operating Assets | -1.25M | -2.46M | -4.43M | -5.59M | -4.94M |
Cash from Operations | -43.06M | -43.99M | -44.14M | -44.25M | -42.85M |
Capital Expenditure | -377.00K | -352.00K | -296.00K | -212.00K | -226.00K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -350.00K | -350.00K | -350.00K | -350.00K | -- |
Cash from Investing | -727.00K | -702.00K | -646.00K | -562.00K | -226.00K |
Total Debt Issued | 21.98M | 21.98M | 21.62M | 0.00 | 0.00 |
Total Debt Repaid | -3.62M | -3.62M | -3.62M | -- | -- |
Issuance of Common Stock | 31.63M | 15.17M | 451.00K | 451.00K | 632.00K |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | 0.00 | 11.63M | 29.80M | 34.80M | 34.80M |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 49.99M | 45.16M | 48.25M | 35.25M | 35.43M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 6.20M | 469.00K | 3.46M | -9.56M | -7.65M |